European Urology Oncology

Scope & Guideline

Empowering professionals with cutting-edge insights in urology and oncology.

Introduction

Welcome to your portal for understanding European Urology Oncology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEUR UROL ONCOL / Eur. Urol. Oncol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'European Urology Oncology' is dedicated to advancing knowledge in the field of urologic oncology, focusing on the latest research and clinical practices related to the diagnosis, treatment, and management of urologic cancers. The journal emphasizes a multidisciplinary approach, integrating various aspects of urology, oncology, and pathology to improve patient outcomes.
  1. Prostate Cancer Research:
    The journal covers extensive research on prostate cancer, including advanced treatment options, diagnostic techniques, and the role of biomarkers in predicting outcomes.
  2. Bladder Cancer Studies:
    Significant attention is given to bladder cancer, focusing on surgical techniques, immunotherapy, and the efficacy of various treatment regimens.
  3. Renal Cell Carcinoma Insights:
    Research on renal cell carcinoma encompasses clinical trials, treatment strategies, and the molecular characteristics of the disease.
  4. Emerging Diagnostic Technologies:
    The journal highlights advancements in imaging techniques such as MRI and PET scans, which are crucial for accurate diagnosis and treatment planning.
  5. Health Economics and Quality of Life:
    There is a focus on assessing the cost-effectiveness of treatments and understanding the impact of cancer therapies on patients' quality of life.
  6. Multidisciplinary Approaches:
    The journal promotes collaborative research efforts, integrating insights from urologists, oncologists, radiologists, and pathologists to enhance treatment outcomes.
The journal 'European Urology Oncology' is at the forefront of addressing emerging trends and themes in urologic oncology, reflecting the evolving landscape of research priorities and clinical practices.
  1. Immunotherapy and Targeted Therapies:
    There is a growing focus on immunotherapeutic approaches and targeted therapies, particularly in the treatment of advanced prostate and bladder cancers, indicating a shift towards more personalized medicine.
  2. Liquid Biopsy and Biomarkers:
    Emerging trends highlight the use of liquid biopsies and genomic biomarkers for early detection and monitoring of treatment response, showcasing advancements in non-invasive diagnostic technologies.
  3. Artificial Intelligence in Oncology:
    The integration of artificial intelligence and machine learning in diagnostics and treatment planning is gaining traction, with studies exploring their applications in improving patient outcomes.
  4. Health Disparities and Access to Care:
    An increasing number of articles address health disparities in cancer care, focusing on access to treatments and the socioeconomic factors affecting patient outcomes.
  5. Quality of Life Assessments:
    Research emphasizing the importance of patient-reported outcomes and quality of life in treatment decision-making is on the rise, reflecting a holistic approach to cancer care.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have shown a decline in emphasis, reflecting shifts in research priorities and advancements in urologic oncology.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focusing solely on traditional surgical approaches, as the field increasingly emphasizes minimally invasive and robotic-assisted techniques.
  2. Basic Science Research:
    The journal has seen a waning interest in purely basic science studies, particularly those not directly linked to clinical applications or translational research.
  3. Single-modality Treatments:
    Research focusing exclusively on single-modality treatments (e.g., surgery or radiation alone) is appearing less frequently, as the trend shifts towards multimodal and personalized treatment approaches.

Similar Journals

Urology Annals

Empowering Urologists with Open Access to Groundbreaking Research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0974-7796Frequency: 6 issues/year

Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

AKTUELLE UROLOGIE

Pioneering Knowledge in Urology for Over 50 Years
Publisher: GEORG THIEME VERLAG KGISSN: 0001-7868Frequency: 6 issues/year

AKTUELLE UROLOGIE is a prominent peer-reviewed journal aimed at advancements in the field of urology, established in 1972 and continuing its commitment to high-quality research through 2024. Published by GEORG THIEME VERLAG KG in Germany, this journal serves as a platform for researchers, clinicians, and students to share innovative findings, critical reviews, and clinical studies that advance urological science and practice. While it currently holds a Q4 category ranking in Urology according to the 2023 metrics, its relevance and targeted contributions provide an invaluable resource for understanding the evolving challenges and treatment modalities within urological care. The journal is accessible via traditional subscription models, supporting a diverse audience in both academic and clinical settings. With an ISSN of 0001-7868 and E-ISSN of 1438-8820, AKTUELLE UROLOGIE continues to be an important reference point for professionals striving to stay abreast of the latest developments in the field.

Current Urology

Fostering Collaboration in the Evolving Field of Urology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1661-7649Frequency: 4 issues/year

Current Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.

Advances in Urology

Advancing Knowledge in Urology and Obstetrics
Publisher: HINDAWI LTDISSN: 1687-6369Frequency: 1 issue/year

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

European Urology Open Science

Innovative Insights for Urological Excellence
Publisher: ELSEVIERISSN: 2666-1691Frequency: 4 issues/year

European Urology Open Science is a premier open-access journal dedicated to advancing the field of urology through publishing high-quality, peer-reviewed research. Published by ELSEVIER in the Netherlands, this journal is recognized for its significant contribution to the medical community, boasting an impressive Q1 ranking in Urology for 2023, indicative of its influence and the quality of research it disseminates. With a focus on innovative studies and interdisciplinary approaches, the European Urology Open Science plays a pivotal role in fostering knowledge exchange and promoting clinical best practices. Researchers, professionals, and students alike benefit from its accessible research format, facilitating a broader dissemination of urological advancements. This journal embraces the Open Access model, ensuring that pioneering findings are readily available to the global scientific community, further enhancing collaboration and knowledge sharing within the field.

Urology Research and Practice

Pioneering research for enhanced urological care.
Publisher: AVESISSN: Frequency: 6 issues/year

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

Prostate Cancer

Leading the way in prostate cancer diagnostics and treatment.
Publisher: HINDAWI LTDISSN: 2090-3111Frequency: 1 issue/year

Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.

PROGRES EN UROLOGIE

Unveiling the Latest in Urological Science
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1166-7087Frequency: 12 issues/year

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.

PROSTATE

Pioneering insights for better male health outcomes.
Publisher: WILEYISSN: 0270-4137Frequency: 16 issues/year

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Asian Journal of Urology

Advancing urological knowledge for a healthier tomorrow.
Publisher: ELSEVIER SINGAPORE PTE LTDISSN: 2214-3882Frequency: 4 issues/year

Asian Journal of Urology is a premier open-access scholarly journal dedicated to advancing the field of urology. Published by Elsevier Singapore Pte Ltd, this journal provides a platform for researchers, clinicians, and students to share impactful findings and innovative practices within urological sciences. Since its inception in 2014, it has established itself as a significant contributor to the discourse in urology, achieving a commendable Q2 ranking in the category of Urology for 2023 and securing the 41st position out of 120 in Scopus rankings, placing it in the 66th percentile amongst its peers. With a commitment to ensuring broad accessibility, all articles are freely available online, promoting widespread dissemination of knowledge. The journal aims to publish high-quality research that informs clinical practices and contributes to the development of urological sciences, making it an essential resource for professionals and scholars in the field.